Literature DB >> 24900836

Design and Evaluation of ω-Hydroxy Fatty Acids Containing α-GalCer Analogues for CD1d-Mediated NKT Cell Activation.

Chaemin Lim1, Jae Hyun Kim1, Dong Jae Baek1, Joo-Youn Lee1, Minjae Cho1, Yoon-Sook Lee1, Chang-Yuil Kang1, Doo Hyun Chung2, Won-Jae Cho3, Sanghee Kim1.   

Abstract

CD1d molecules recognize glycolipid antigens with straight chain fatty acid moieties. Although most of the residues in the CD1d binding groove are hydrophobic, some of the amino acids can form hydrogen bonds. Consequently, we have designed ω-hydroxy fatty acid-containing glycolipid derivatives of the prototypical CD1d ligand α-GalCer. The potency of the ω-hydroxy analogues of the proper length is comparable to that of α-GalCer. We propose, based on the biological results and molecular modeling studies, that a hydrogen bonding interaction is involved between the ω-hydroxy group and a polar amino acid residue in the hydrophobic binding groove.

Entities:  

Keywords:  CD1d; NKT cell activator; drug design; hydrogen bonding interaction; α-Galactosylceramide

Year:  2014        PMID: 24900836      PMCID: PMC4027640          DOI: 10.1021/ml400517b

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  29 in total

Review 1.  Toward an understanding of NKT cell biology: progress and paradoxes.

Authors:  Mitchell Kronenberg
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation.

Authors:  Barbara Giabbai; Stèphane Sidobre; M D Max Crispin; Yovan Sanchez-Ruìz; Angela Bachi; Mitchell Kronenberg; Ian A Wilson; Massimo Degano
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

3.  Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.

Authors:  Masakazu Fujio; Douglass Wu; Raquel Garcia-Navarro; David D Ho; Moriya Tsuji; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2006-07-19       Impact factor: 15.419

4.  Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide).

Authors:  Masao Shiozaki; Takuya Tashiro; Hiroyuki Koshino; Tomokuni Shigeura; Hiroshi Watarai; Masaru Taniguchi; Kenji Mori
Journal:  Carbohydr Res       Date:  2013-02-04       Impact factor: 2.104

Review 5.  Immunotherapeutic potential for ceramide-based activators of iNKT cells.

Authors:  Celia R Berkers; Huib Ovaa
Journal:  Trends Pharmacol Sci       Date:  2005-05       Impact factor: 14.819

6.  Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.

Authors:  André Schiefner; Masakazu Fujio; Douglass Wu; Chi-Huey Wong; Ian A Wilson
Journal:  J Mol Biol       Date:  2009-09-02       Impact factor: 5.469

7.  Efficient synthesis of alpha-galactosyl ceramide analogues using glycosyl iodide donors.

Authors:  Wenjun Du; Jacquelyn Gervay-Hague
Journal:  Org Lett       Date:  2005-05-12       Impact factor: 6.005

8.  Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.

Authors:  Daniel G Pellicci; Onisha Patel; Lars Kjer-Nielsen; Siew Siew Pang; Lucy C Sullivan; Konstantinos Kyparissoudis; Andrew G Brooks; Hugh H Reid; Stephanie Gras; Isabelle S Lucet; Ruide Koh; Mark J Smyth; Thierry Mallevaey; Jennifer L Matsuda; Laurent Gapin; James McCluskey; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

Review 9.  Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions.

Authors:  Anna Balato; Derya Unutmaz; Anthony A Gaspari
Journal:  J Invest Dermatol       Date:  2009-03-05       Impact factor: 8.551

10.  The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.

Authors:  Jacinto López-Sagaseta; Jennifer E Kung; Paul B Savage; Jenny Gumperz; Erin J Adams
Journal:  PLoS Biol       Date:  2012-10-23       Impact factor: 8.029

View more
  6 in total

1.  Synthesis and Biological Activities of 5-Thio-α-GalCers.

Authors:  Jingjing Bi; Jing Wang; Kai Zhou; Yuancheng Wang; Min Fang; Yuguo Du
Journal:  ACS Med Chem Lett       Date:  2015-02-11       Impact factor: 4.345

2.  Improved Th17 Selectivity of α-Galactosylceramide via Noncovalent Interactions with Diether Moiety.

Authors:  Yoon Soo Hwang; Junhyeong Yim; Heebum Song; Seung Bum Park
Journal:  ACS Med Chem Lett       Date:  2019-04-04       Impact factor: 4.345

3.  Development of α-GalCer Analogues with an α-Fluorocarbonyl Moiety as Th2-Selective Ligands of CD1d.

Authors:  Hyunsoo Kim; Heebum Song; Jun-Gyu Park; Dong-Sup Lee; Seung Bum Park
Journal:  ACS Med Chem Lett       Date:  2019-04-24       Impact factor: 4.345

4.  Synthesis of Chrysogeside B from Halotolerant Fungus Penicillium and Its Antimicrobial Activities Evaluation.

Authors:  Ruiquan Liu; Lei Wang; Qibo Li; Min Liao; Zhikun Yang; Yun Huang; Cong Lv; Bing Zheng; Jiangchun Zhong; Qinghua Bian; Min Wang; Shangzhong Liu
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

5.  A Designed α-GalCer Analog Promotes Considerable Th1 Cytokine Response by Activating the CD1d-iNKT Axis and CD11b-Positive Monocytes/Macrophages.

Authors:  Juan Ma; Peng He; Chuanfang Zhao; Quanzhong Ren; Zheng Dong; Jiahuang Qiu; Yang Jing; Sijin Liu; Yuguo Du
Journal:  Adv Sci (Weinh)       Date:  2020-06-08       Impact factor: 16.806

6.  Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor.

Authors:  Wenjin Li; Joren Guillaume; Younis Baqi; Isabell Wachsmann; Volkmar Gieselmann; Serge Van Calenbergh; Christa E Müller
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.